Engimmune Therapeutics
Edit

Engimmune Therapeutics

https://www.engimmune.com/
Last activity: 22.12.2023
Mentions
6
Employees: 1-10
Total raised: $16.7M

Funding Rounds 1

DateSeriesAmountInvestors
03.05.2022Seed$16.7M-

Mentions in press and media 6

DateTitleDescriptionSource
22.12.2023Clinical progress for three Biotechs DIAMOND-1 (DIAbetic Macular edema patients ON a Drop) Phase 3 trial by Oculis’ OCS-01 eye drops ai...startuptic...
13.07.2023Startups gather Board members’ expertise Versameb is transforming (m)RNA therapeutics to cure hard-to-treat and/or prevalent diseases with ...startuptic...
10.05.2023Leadership changes in startups' C-Suites Engimmune Therapeutics AG, a Swiss biotech company developing novel T-cell receptor (TCR)-based th...startuptic...
05.05.2022Switzerland's Engimmune Therapeutics scores €15M seedEngimmune Therapeutics has received 15.5 million Swiss francs (about €15 million) in a round led by ...pitchbook....
03.05.2022Engimmune Therapeutics raises CHF 15.5 million in seed finan... TCR-based therapies are an emerging class of drugs, however, when developing therapies, the challe...startuptic...
03.05.2022Engimmune Therapeutics Raises CHF 15.5M in Seed FinancingEngimmune Therapeutics, a Basel, Switzerland-based biotech company developing novel T-cell receptor ...finsmes.co...

Reviews 0

Sign up to leave a review

Sign up Log In